Insider Transactions in Q2 2021 at Poseida Therapeutics, Inc. (PSTX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+18.88%
|
$5,000
$1.32 P/Share
|
|
Jun 11
2021
|
Matthew A. Spear Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-19.53%
|
$36,000
$9.44 P/Share
|
|
Jun 11
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+16.34%
|
$4,000
$1.32 P/Share
|
|
Jun 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
40,722
-0.56%
|
$325,776
$8.34 P/Share
|
|
Jun 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
41,194
-0.56%
|
$329,552
$8.61 P/Share
|
|
May 04
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
35,986
-0.49%
|
$287,888
$8.44 P/Share
|
|
May 03
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
18,326
-0.25%
|
$164,934
$9.01 P/Share
|
|
Apr 23
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.27%
|
$5,000
$1.32 P/Share
|
|
Apr 21
2021
|
Matthew A. Spear Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-25.83%
|
$32,000
$8.44 P/Share
|
|
Apr 21
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+20.53%
|
$4,000
$1.32 P/Share
|
|
Apr 05
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
57,819
-0.39%
|
$520,371
$9.97 P/Share
|
|
Apr 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
57,181
-0.76%
|
$514,629
$9.55 P/Share
|